Holger Fröhlich (Holger Froehlich)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Venues

PloS one

The EPMA journal

NPJ Parkinson's disease

Scientific reports

Fraunhofer SCAI

University of Tübingen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fraunhofer SCAI Dec 01 2019

Germany

Head of AI & Data Science :: Business Area Bioinformatics

University of Bonn Apr 01 2016

Germany

honorary professor, adjunct group leader

Education History

University of Tübingen Mar 01 2003 - Dec 22 2006

Germany

PHD

Publications

Tom Hähnel, Tamara Raschka, Stefano Sapienza, Jochen Klucken, Enrico Glaab, Jean-Christophe Corvol, Björn H Falkenburger, Holger Fröhlich
Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis. NPJ Parkinson's disease 10 (1) (2024)
Jonas Botz, Diego Valderrama, Jannis Guski, Holger Fröhlich
A dynamic ensemble model for short-term forecasting in pandemic situations. PLOS global public health 4 (8) (2024)
Tamara Raschka, Zexin Li, Heiko Gaßner, Zacharias Kohl, Jelena Jukic, Franz Marxreiter, Holger Fröhlich
Unraveling progression subtypes in people with Huntington's disease. The EPMA journal 15 (2) (2024)
Tamara Raschka, Zexin Li, Heiko Gaßner, Zacharias Kohl, Jelena Jukic, Franz Marxreiter, Holger Fröhlich
Unraveling progression subtypes in people with Huntington's disease. The EPMA journal 15 (2) (2024)
Cyril Brzenczek, Quentin Klopfenstein, Tom Hähnel, Holger Fröhlich, Enrico Glaab, null null
Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease. NPJ digital medicine 7 (1) (2024)
Tamara Raschka, Zexin Li, Heiko Gaßner, Zacharias Kohl, Jelena Jukic, Franz Marxreiter, Holger Fröhlich
Unraveling progression subtypes in people with Huntington's disease. The EPMA journal 15 (2) (2024)
Olga Teplytska, Moritz Ernst, Luca Marie Koltermann, Diego Valderrama, Elena Trunz, Marc Vaisband, Jan Hasenauer, Holger Fröhlich, Ulrich Jaehde
Machine Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review. Clinical pharmacokinetics (2024)
Tom Hähnel, Tamara Raschka, Stefano Sapienza, Jochen Klucken, Enrico Glaab, Jean-Christophe Corvol, Björn H Falkenburger, Holger Fröhlich
Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis. NPJ Parkinson's disease 10 (1) (2024)
Jonas Botz, Diego Valderrama, Jannis Guski, Holger Fröhlich
A dynamic ensemble model for short-term forecasting in pandemic situations. PLOS global public health 4 (8) (2024)
Tom Hähnel, Tamara Raschka, Stefano Sapienza, Jochen Klucken, Enrico Glaab, Jean-Christophe Corvol, Björn H Falkenburger, Holger Fröhlich
Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis. NPJ Parkinson's disease 10 (1) (2024)
Gul Erdemli, Margarita Grammatikopoulou, Bertil Wagner, Srinivasan Vairavan, Jelena Curcic, Dag Aarsland, Gayle Wittenberg, Spiros Nikolopoulos, Marijn Muurling, Holger Fröhlich, Casper de Boer, Niraj M Shanbhag, Vera J M Nies, Neva Coello, Dianne Gove, Ana Diaz, Suzanne Foy, Wim Dartee, Anna-Katharine Brem
Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research. NPJ digital medicine 7 (1) (2024)
Tamara Raschka, Zexin Li, Heiko Gaßner, Zacharias Kohl, Jelena Jukic, Franz Marxreiter, Holger Fröhlich
Unraveling progression subtypes in people with Huntington's disease. The EPMA journal 15 (2) (2024)
Meemansa Sood, Ulrike Suenkel, Anna-Katharina von Thaler, Helena U Zacharias, Kathrin Brockmann, Gerhard W Eschweiler, Walter Maetzler, Daniela Berg, Holger Fröhlich, Sebastian Heinzel
Bayesian network modeling of risk and prodromal markers of Parkinson's disease. PloS one 18 (2) (2023)
Meemansa Sood, Ulrike Suenkel, Anna-Katharina von Thaler, Helena U Zacharias, Kathrin Brockmann, Gerhard W Eschweiler, Walter Maetzler, Daniela Berg, Holger Fröhlich, Sebastian Heinzel
Bayesian network modeling of risk and prodromal markers of Parkinson's disease. PloS one 18 (2) (2023)
Meemansa Sood, Ulrike Suenkel, Anna-Katharina von Thaler, Helena U Zacharias, Kathrin Brockmann, Gerhard W Eschweiler, Walter Maetzler, Daniela Berg, Holger Fröhlich, Sebastian Heinzel
Bayesian network modeling of risk and prodromal markers of Parkinson's disease. PloS one 18 (2) (2023)
Meemansa Sood, Ulrike Suenkel, Anna-Katharina von Thaler, Helena U Zacharias, Kathrin Brockmann, Gerhard W Eschweiler, Walter Maetzler, Daniela Berg, Holger Fröhlich, Sebastian Heinzel
Bayesian network modeling of risk and prodromal markers of Parkinson's disease. PloS one 18 (2) (2023)
Sied Kebir, Vivien Ullrich, Pia Berger, Celia Dobersalske, Sarah Langer, Laurèl Rauschenbach, Daniel Trageser, Andreas Till, Franziska K Lorbeer, Anja Wieland, Timo Wilhelm-Buchstab, Ashar Ahmad, Holger Fröhlich, Igor Cima, Shruthi Prasad, Johann Matschke, Verena Jendrossek, Marc Remke, Barbara M Grüner, Alexander Roesch, Jens Thomas Siveke, Christel Herold-Mende, Tobias Blau, Kathy Keyvani, Frank K H van Landeghem, Torsten Pietsch, Jörg Felsberg, Guido Reifenberger, Michael Weller, Ulrich Sure, Oliver Brüstle, Matthias Simon, Martin Glas, Björn Scheffler
A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Manuel Lentzen, Sumit Madan, Vanessa Lage-Rupprecht, Lisa Kühnel, Juliane Fluck, Marc Jacobs, Mirja Mittermaier, Martin Witzenrath, Peter Brunecker, Martin Hofmann-Apitius, Joachim Weber, Holger Fröhlich
Critical assessment of transformer-based AI models for German clinical notes. JAMIA open 5 (4) (2022)
Ramon Diaz-Uriarte, Elisa Gómez de Lope, Rosalba Giugno, Holger Fröhlich, Petr V Nazarov, Isabel A Nepomuceno-Chamorro, Armin Rauschenberger, Enrico Glaab
Ten quick tips for biomarker discovery and validation analyses using machine learning. PLoS computational biology 18 (8) (2022)
Oliver Kaut, Ina Schmitt, Fabian Stahl, Holger Fröhlich, Per Hoffmann, Frank J Gonzalez, Karin U Loeffler
Epigenome-Wide Analysis of DNA Methylation in Parkinson's Disease Cortex. Life (Basel, Switzerland) 12 (4) (2022)
Ingo G H Schmidt-Wolf, Jens Müller, Karin Schuetze, Verena Rolfes, Rosi Bissinger, Nathalia Rosero, Ashar Ahmad, Bernardo Simoes Franklin, Berndt Zur, Holger Fröhlich, Florian Lang, Johannes Oldenburg, Bernd Pötzsch, Karin U Loeffler
Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease. Biology 10 (8) (2021)
Amina Lemsara, Salima Ouadfel, Holger Fröhlich
PathME: pathway based multi-modal sparse autoencoders for clustering of patient-level multi-omics data. BMC bioinformatics 21 (1) (2020)
Meemansa Sood, Akrishta Sahay, Reagon Karki, Mohammad Asif Emon, Henri Vrooman, Martin Hofmann-Apitius, Holger Fröhlich
Realistic simulation of virtual multi-scale, multi-modal patient trajectories using Bayesian networks and sparse auto-encoders. Scientific reports 10 (1) (2020)
Xiaoxiao Zhang, Holger Fröhlich, Dima Grigoriev, Sergey Vakulenko, Jörg Zimmermann, Andreas Günter Weber
A Simple 3-Parameter Model for Cancer Incidences. Scientific reports 8 (1) (2018)
Holger Fröhlich, Rudi Balling, Niko Beerenwinkel, Oliver Kohlbacher, Santosh Kumar, Thomas Lengauer, Marloes H Maathuis, Yves Moreau, Susan A Murphy, Teresa M Przytycka, Michael Rebhan, Hannes Röst, Andreas Schuppert, Matthias Schwab, Rainer Spang, Daniel Stekhoven, Jimeng Sun, Andreas Weber, Daniel Ziemek, Blaz Zupan
From hype to reality: data science enabling personalized medicine. BMC medicine 16 (1) (2018)
Ingo G H Schmidt-Wolf, Tikam Chand Dakal, Michael Ludwig, Holger Fröhlich, Riya Mathur, Heiko Martin Reutter
Towards a Central Role of ISL1 in the Bladder Exstrophy⁻Epispadias Complex (BEEC): Computational Characterization of Genetic Variants and Structural Modelling. Genes 9 (12) (2018)
Shashank Khanna, Daniel Domingo-Fernández, Anandhi Iyappan, Mohammad Asif Emon, Martin Hofmann-Apitius, Holger Fröhlich
Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms. Scientific reports 8 (1) (2018)
Navin Sarin, Florian Engel, Florian Rothweiler, Jindrich Cinatl, Martin Michaelis, Roland Frötschl, Holger Fröhlich, Ganna V Kalayda
Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. International journal of molecular sciences 19 (3) (2018)

Holger Fröhlich.css-eqlu8i{font-size:small;padding-left:4px;} (Holger Froehlich)

Publication Activity (10 Years)

Top Topics

Top Venues

Holger Fröhlich (Holger Froehlich)